LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical Officer

RTTNews | 954 days ago
LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical Officer

(RTTNews) - Immuno-oncology company LAVA Therapeutics N.V. (LVTX) announced Monday that Dr. Charles Morris has joined LAVA as chief medical officer effective February 6, 2023. Dr. Morris will replace Benjamin Winograd.

Dr. Morris is a medical oncologist with over 25 years of oncology drug development experience working with global biotech and pharmaceutical companies and managing numerous drug approvals.

Most recently, he was the chief medical officer for biotechnology company Celyad Oncology. He also served as chief medical officer of Radius Health and held leadership positions at PsiOxus Therapeutics, ImmunoGen and Allos Therapeutics.

He was also vice president of worldwide clinical research at Cephalon where he supported the approval of TREANDA (bendamustine) for the treatment of indolent non-Hodgkin lymphoma and chronic lymphocytopenia.

He began his career at AstraZeneca and held roles of increasing responsibility including global medical lead for Faslodex (fulvestrant) which he managed through its approval for breast cancer.

read more
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Thursday, following the mixed cues from Wall Street overnight, after the US Fed delivered a widely expected quarter point interest rates cut to 4.0 percent, citing a shift in the balance of risks. The latest projections from Fed officials also suggest they expect the central bank to lower rates two more times this year.
RTTNews | 8 minutes ago
Japanese Market Notably Higher

Japanese Market Notably Higher

The Japanese market is trading notably higher on Thursday, reversing the losses in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is moving above the 45,000 mark, with gains across most sectors led by exporters and technology stocks.
RTTNews | 1h 37min ago
Australian Market Modestly Lower

Australian Market Modestly Lower

The Australian market is trading modestly lower on Thursday, extending the losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,800 level, with weakness across most sectors led by mining and energy stocks.
RTTNews | 2h 18min ago
U.S. Dollar Advances After Fed Decision

U.S. Dollar Advances After Fed Decision

The U.S. dollar climbed against its major counterparts in the New York session on Wednesday, as the Federal Reserve cut its key interest rate and projected two more reductions for this year.
RTTNews | 4h 54min ago
Fed Cuts Rates By Quarter Point, Forecasts Two More Rate Cuts This Year

Fed Cuts Rates By Quarter Point, Forecasts Two More Rate Cuts This Year

In a widely expected move, the Federal Reserve on Wednesday announced that it has decided to lower interest rates by a quarter point, marking the first rate cut of 2025. The Fed said it decided to lower the target range for the federal funds rate by 25 basis points to 4.0 percent to 4.25 percent, citing a shift in the balance of risks.
RTTNews | 8h 52min ago
Swiss Market Ends Marginally Down

Swiss Market Ends Marginally Down

After a weak start and a subsequent long spell in negative territory, the Switzerland market briefly moved above the flat line in late afternoon trade on Wednesday, but failed to sustain momentum and settled marginally down with a few frontline stocks turning weak again.
RTTNews | 9h 19min ago